Clinical Trials
2 trialsNCT00896480 2021-04-08
Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma
GlaxoSmithKline
Phase 2 Completed
NCT01149343 2020-11-20
Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer
GlaxoSmithKline
Phase 1 Completed